BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hua L, Wang Z, Zhao L, Mao H, Wang G, Zhang K, Liu X, Wu D, Zheng Y, Lu J, Yu R, Liu H. Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy. Theranostics 2018;8:5088-105. [PMID: 30429888 DOI: 10.7150/thno.26225] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Habib S, Singh M. Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review. Polymers 2022;14:712. [DOI: 10.3390/polym14040712] [Reference Citation Analysis]
2 Zhang L, Zhang Y, Zhao G, Yang H, Wang X, Yu R, Liu H, Li S. Preparation of Poly(MTZ) n -(DMAEMA) m Micelles and Study on Their Antibacterial Property. ACS Omega 2020;5:23053-61. [PMID: 32954155 DOI: 10.1021/acsomega.0c02774] [Reference Citation Analysis]
3 Cui J, Xu Y, Tu H, Zhao H, Wang H, Di L, Wang R. Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas. Acta Pharmaceutica Sinica B 2022;12:1100-25. [DOI: 10.1016/j.apsb.2021.08.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhu Y, Jia J, Zhao G, Huang X, Wang L, Zhang Y, Zhang L, Konduru N, Xie J, Yu R, Liu H. Multi-responsive nanofibers composite gel for local drug delivery to inhibit recurrence of glioma after operation. J Nanobiotechnology 2021;19:198. [PMID: 34217325 DOI: 10.1186/s12951-021-00943-z] [Reference Citation Analysis]
5 Wang X, Liu G, Chen N, Wu J, Zhang J, Qian Y, Zhang L, Zhou D, Yu Y. Angiopep2-Conjugated Star-Shaped Polyprodrug Amphiphiles for Simultaneous Glioma-Targeting Therapy and MR Imaging. ACS Appl Mater Interfaces 2020;12:12143-54. [PMID: 32078286 DOI: 10.1021/acsami.0c00509] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
6 Chang L, Zhang Y, Li M, Zhao X, Wang D, Liu J, Zhou F, Zhang J. Nanostructured lipid carrier co-delivering paclitaxel and doxorubicin restrains the proliferation and promotes apoptosis of glioma stem cells via regulating PI3K/Akt/mTOR signaling. Nanotechnology 2021;32:225101. [PMID: 33690190 DOI: 10.1088/1361-6528/abd439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Javani S, Barsbay M, Ghaffarlou M, Mousazadeh N, Mohammadi A, Mozafari F, Rezaeejam H, Nasehi L, Nosrati H, Kavetskyy T, Danafar H. Metronidazole conjugated bismuth sulfide nanoparticles for enhanced X-ray radiation therapy. Journal of Drug Delivery Science and Technology 2022;71:103336. [DOI: 10.1016/j.jddst.2022.103336] [Reference Citation Analysis]
8 Lepeltier E, Rijo P, Rizzolio F, Popovtzer R, Petrikaite V, Assaraf YG, Passirani C. Nanomedicine to target multidrug resistant tumors. Drug Resist Updat 2020;52:100704. [PMID: 32512316 DOI: 10.1016/j.drup.2020.100704] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
9 Madamsetty VS, Mukherjee A, Mukherjee S. Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics. Front Pharmacol 2019;10:1264. [PMID: 31708785 DOI: 10.3389/fphar.2019.01264] [Cited by in Crossref: 52] [Cited by in F6Publishing: 29] [Article Influence: 17.3] [Reference Citation Analysis]
10 Xie A, Hanif S, Ouyang J, Tang Z, Kong N, Kim NY, Qi B, Patel D, Shi B, Tao W. Stimuli-responsive prodrug-based cancer nanomedicine. EBioMedicine 2020;56:102821. [PMID: 32505922 DOI: 10.1016/j.ebiom.2020.102821] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
11 Ngowi EE, Wang YZ, Qian L, Helmy YASH, Anyomi B, Li T, Zheng M, Jiang ES, Duan SF, Wei JS, Wu DD, Ji XY. The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders. Front Bioeng Biotechnol 2021;9:629832. [PMID: 33738278 DOI: 10.3389/fbioe.2021.629832] [Reference Citation Analysis]
12 Hu D, Pan M, Yu Y, Sun A, Shi K, Qu Y, Qian Z. Application of nanotechnology for enhancing photodynamic therapy via ameliorating, neglecting, or exploiting tumor hypoxia. View 2020;1. [DOI: 10.1002/viw2.6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
13 Forest CR, Silva CAC, Thordarson P. Dual‐peptide functionalized nanoparticles for therapeutic use. Peptide Science 2021;113. [DOI: 10.1002/pep2.24205] [Reference Citation Analysis]
14 Hegde MM, Prabhu S, Mutalik S, Chatterjee A, Goda JS, Satish Rao BS. Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches. J Pharm Investig 2022;52:49-74. [DOI: 10.1007/s40005-021-00548-6] [Reference Citation Analysis]
15 Kakkad S, Krishnamachary B, Jacob D, Pacheco-Torres J, Goggins E, Bharti SK, Penet MF, Bhujwalla ZM. Molecular and functional imaging insights into the role of hypoxia in cancer aggression. Cancer Metastasis Rev 2019;38:51-64. [PMID: 30840168 DOI: 10.1007/s10555-019-09788-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
16 Chen T, Su L, Lin L, Ge X, Bai F, Niu M, Wang C, Song J, Guo S, Yang H. Mesoporous radiosensitized nanoprobe for enhanced NIR-II photoacoustic imaging-guided accurate radio-chemotherapy. Nano Res . [DOI: 10.1007/s12274-021-3997-4] [Reference Citation Analysis]
17 Wang Y, Zhang C, Lu W, Chen R, Yu M. Establishment of a prognostic-related microRNAs risk model for glioma by bioinformatics analysis. Ann Transl Med 2021;9:1022. [PMID: 34277822 DOI: 10.21037/atm-21-2402] [Reference Citation Analysis]
18 Chen YA, Lai YR, Wu HY, Lo YJ, Chang YF, Hung CL, Lin CJ, Lo UG, Lin H, Hsieh JT, Chiu CH, Lin YH, Lai CH. Bacterial Genotoxin-Coated Nanoparticles for Radiotherapy Sensitization in Prostate Cancer. Biomedicines 2021;9:151. [PMID: 33557143 DOI: 10.3390/biomedicines9020151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wang S, Zhang F, Yu G, Wang Z, Jacobson O, Ma Y, Tian R, Deng H, Yang W, Chen ZY, Chen X. Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery. Theranostics 2020;10:6629-37. [PMID: 32550894 DOI: 10.7150/thno.47849] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
20 Zhou H, Qin F, Chen C. Designing Hypoxia-Responsive Nanotheranostic Agents for Tumor Imaging and Therapy. Adv Healthc Mater 2021;10:e2001277. [PMID: 32985141 DOI: 10.1002/adhm.202001277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Xu H, Han Y, Zhao G, Zhang L, Zhao Z, Wang Z, Zhao L, Hua L, Naveena K, Lu J, Yu R, Liu H. Hypoxia-Responsive Lipid-Polymer Nanoparticle-Combined Imaging-Guided Surgery and Multitherapy Strategies for Glioma. ACS Appl Mater Interfaces 2020;12:52319-28. [PMID: 33166112 DOI: 10.1021/acsami.0c12971] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
22 Kanth S, Malgar Puttaiahgowda Y, Nagaraja A, Bukva M. Recent advances in development of poly (dimethylaminoethyl methacrylate) antimicrobial polymers. European Polymer Journal 2022;163:110930. [DOI: 10.1016/j.eurpolymj.2021.110930] [Reference Citation Analysis]
23 Xie Y, Han Y, Zhang X, Ma H, Li L, Yu R, Liu H. Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma. Front Oncol 2021;11:633827. [PMID: 33869019 DOI: 10.3389/fonc.2021.633827] [Reference Citation Analysis]
24 Wang S, Yu G, Wang Z, Jacobson O, Lin L, Yang W, Deng H, He Z, Liu Y, Chen Z, Chen X. Enhanced Antitumor Efficacy by a Cascade of Reactive Oxygen Species Generation and Drug Release. Angew Chem 2019;131:14900-5. [DOI: 10.1002/ange.201908997] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
25 Li X, Geng X, Chen Z, Yuan Z. Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106218] [Reference Citation Analysis]
26 Mi P. Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics. Theranostics 2020;10:4557-88. [PMID: 32292515 DOI: 10.7150/thno.38069] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 42.5] [Reference Citation Analysis]
27 Zhang C, Li Q, Wu C, Wang J, Su M, Deng J. Hypoxia-responsive nanogel as IL-12 carrier for anti-cancer therapy. Nanotechnology 2021;32:095107. [DOI: 10.1088/1361-6528/abcdcc] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Wang S, Yu G, Wang Z, Jacobson O, Lin LS, Yang W, Deng H, He Z, Liu Y, Chen ZY, Chen X. Enhanced Antitumor Efficacy by a Cascade of Reactive Oxygen Species Generation and Drug Release. Angew Chem Int Ed Engl 2019;58:14758-63. [PMID: 31429173 DOI: 10.1002/anie.201908997] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 25.3] [Reference Citation Analysis]
29 Jia L, Song Y, Mu L, Li Q, Tang J, Yang Z, Meng W. Long noncoding RNA TPT1‐AS1 downregulates the microRNA‐770‐5p expression to inhibit glioma cell autophagy and promote proliferation through STMN1 upregulation. J Cell Physiol 2020;235:3679-89. [DOI: 10.1002/jcp.29262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
30 Peng L, Ming Y, Zhang L, Zhou J, Xiang W, Zeng S, He H, Chen L. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway. FASEB J 2020;34:5128-43. [PMID: 32067282 DOI: 10.1096/fj.201802629RR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Ruiz-Garcia H, Alvarado-Estrada K, Krishnan S, Quinones-Hinojosa A, Trifiletti DM. Nanoparticles for Stem Cell Therapy Bioengineering in Glioma. Front Bioeng Biotechnol 2020;8:558375. [PMID: 33365304 DOI: 10.3389/fbioe.2020.558375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Kumari R, Sunil D, Ningthoujam RS. Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review. J Control Release 2020;319:135-56. [PMID: 31881315 DOI: 10.1016/j.jconrel.2019.12.041] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 18.0] [Reference Citation Analysis]
33 Lv S, Long W, Chen J, Ren Q, Wang J, Mu X, Liu H, Zhang X, Zhang R. Dual pH-triggered catalytic selective Mn clusters for cancer radiosensitization and radioprotection. Nanoscale 2020;12:548-57. [DOI: 10.1039/c9nr08192e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
34 Bhargav AG, Mondal SK, Garcia CA, Green JJ, Quiñones‐hinojosa A. Nanomedicine Revisited: Next Generation Therapies for Brain Cancer. Adv Therap 2020;3:2000118. [DOI: 10.1002/adtp.202000118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Sundaram A, Peng L, Chai L, Xie Z, Ponraj JS, Wang X, Wang G, Zhang B, Nie G, Xie N, Rajesh Kumar M, Zhang H. Advanced nanomaterials for hypoxia tumor therapy: challenges and solutions. Nanoscale 2020;12:21497-518. [DOI: 10.1039/d0nr06271e] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Bilynsky C, Millot N, Papa A. Radiation nanosensitizers in cancer therapy—From preclinical discoveries to the outcomes of early clinical trials. Bioengineering & Transla Med 2022;7. [DOI: 10.1002/btm2.10256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Chen C, Zhang S, Zhang R, Sun P, Shi C, Abdalla M, Li A, Xu J, Du W, Zhang J, Liu Y, Tang C, Yang Z, Jiang X. In situ tuning proangiogenic factor-mediated immunotolerance synergizes the tumoricidal immunity via a hypoxia-triggerable liposomal bio-nanoreactor. Theranostics 2020;10:11998-2010. [PMID: 33204325 DOI: 10.7150/thno.50806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
38 Yang Z, Song J, Tang W, Fan W, Dai Y, Shen Z, Lin L, Cheng S, Liu Y, Niu G, Rong P, Wang W, Chen X. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging. Theranostics 2019;9:526-36. [PMID: 30809290 DOI: 10.7150/thno.30779] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 19.0] [Reference Citation Analysis]
39 Zhang J, Liu Y, Wang X, Du J, Song K, Li B, Chang H, Ouyang R, Miao Y, Sun Y, Li Y. Nanozyme-Incorporated Biodegradable Bismuth Mesoporous Radiosensitizer for Tumor Microenvironment-Modulated Hypoxic Tumor Thermoradiotherapy. ACS Appl Mater Interfaces 2020;12:57768-81. [DOI: 10.1021/acsami.0c18853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
40 Yang Y, Zeng W, Huang P, Zeng X, Mei L. Smart materials for drug delivery and cancer therapy. View 2021;2:20200042. [DOI: 10.1002/viw.20200042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
41 Boyd NH, Tran AN, Bernstock JD, Etminan T, Jones AB, Gillespie GY, Friedman GK, Hjelmeland AB. Glioma stem cells and their roles within the hypoxic tumor microenvironment. Theranostics 2021;11:665-83. [PMID: 33391498 DOI: 10.7150/thno.41692] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
42 Hou X, Chang Y, Yue Y, Wang Z, Ding F, Li Z, Li H, Xu Y, Kong X, Huang F, Guo D, Liu J. Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle. Advanced Science. [DOI: 10.1002/advs.202104349] [Reference Citation Analysis]
43 Wei J, Wu D, Shao Y, Guo B, Jiang J, Chen J, Zhang J, Meng F, Zhong Z. ApoE-mediated systemic nanodelivery of granzyme B and CpG for enhanced glioma immunotherapy. J Control Release 2022:S0168-3659(22)00244-9. [PMID: 35513207 DOI: 10.1016/j.jconrel.2022.04.048] [Reference Citation Analysis]
44 Ruiz-Garcia H, Ramirez-Loera C, Malouff TD, Seneviratne DS, Palmer JD, Trifiletti DM. Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma. Int J Mol Sci 2021;22:9673. [PMID: 34575840 DOI: 10.3390/ijms22189673] [Reference Citation Analysis]
45 Moradi Kashkooli F, Soltani M, Souri M. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies. J Control Release 2020;327:316-49. [PMID: 32800878 DOI: 10.1016/j.jconrel.2020.08.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
46 Tang W, Fan W, Lau J, Deng L, Shen Z, Chen X. Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics. Chem Soc Rev 2019;48:2967-3014. [DOI: 10.1039/c8cs00805a] [Cited by in Crossref: 123] [Cited by in F6Publishing: 49] [Article Influence: 41.0] [Reference Citation Analysis]
47 Lim SH, Li CH, Jeong YI, Jang WY, Choi JM, Jung S. Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models. Int J Nanomedicine 2019;14:8861-74. [PMID: 32009784 DOI: 10.2147/IJN.S227894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
48 Luo Y, Yang H, Zhou YF, Hu B. Dual and multi-targeted nanoparticles for site-specific brain drug delivery. J Control Release 2020;317:195-215. [PMID: 31794799 DOI: 10.1016/j.jconrel.2019.11.037] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
49 Long M, Lu A, Lu M, Weng L, Chen Q, Zhu L, Chen Z. Azo-inserted responsive hybrid liposomes for hypoxia-specific drug delivery. Acta Biomater 2020;115:343-57. [PMID: 32771598 DOI: 10.1016/j.actbio.2020.07.061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
50 Zhao Z, Shen J, Zhang L, Wang L, Xu H, Han Y, Jia J, Lu Y, Yu R, Liu H. Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation. Biomater Sci 2020;8:5306-16. [PMID: 32573615 DOI: 10.1039/d0bm00338g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
51 Park H, Saravanakumar G, Kim J, Lim J, Kim WJ. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics. Adv Healthc Mater 2021;10:e2000834. [PMID: 33073497 DOI: 10.1002/adhm.202000834] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
52 Liao J, Jia Y, Wu Y, Shi K, Yang D, Li P, Qian Z. Physical‐, chemical‐, and biological‐responsive nanomedicine for cancer therapy. WIREs Nanomed Nanobiotechnol 2020;12. [DOI: 10.1002/wnan.1581] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
53 Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol Res 2021;171:105780. [PMID: 34302977 DOI: 10.1016/j.phrs.2021.105780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Feng X, Dixon H, Glen‐ravenhill H, Karaosmanoglu S, Li Q, Yan L, Chen X. Smart Nanotechnologies to Target Tumor with Deep Penetration Depth for Efficient Cancer Treatment and Imaging. Adv Therap 2019;2:1900093. [DOI: 10.1002/adtp.201900093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]